APA (7th ed.) Citation

MA, T., S, A., H, N., TM, L., TJ, S., TR, R., . . . M, B. (2021). A Patient-Derived Orthotopic Xenograft Model of Gastroesophageal-Junction Adenocarcinoma Translated to the Clinic by Tumor-Targeting Fluorescent Antibodies to Carcinoembryonic-Antigen-Related Cell-Adhesion Molecules. In vivo (Athens, Greece), 35(4), 1959. https://doi.org/10.21873/invivo.12463

Chicago Style (17th ed.) Citation

MA, Turner, Amirfakhri S, Nishino H, Lwin TM, Savides TJ, Reid TR, Singer BB, Hoffman RM, and Bouvet M. "A Patient-Derived Orthotopic Xenograft Model of Gastroesophageal-Junction Adenocarcinoma Translated to the Clinic by Tumor-Targeting Fluorescent Antibodies to Carcinoembryonic-Antigen-Related Cell-Adhesion Molecules." In Vivo (Athens, Greece) 35, no. 4 (2021): 1959. https://doi.org/10.21873/invivo.12463.

MLA (9th ed.) Citation

MA, Turner, et al. "A Patient-Derived Orthotopic Xenograft Model of Gastroesophageal-Junction Adenocarcinoma Translated to the Clinic by Tumor-Targeting Fluorescent Antibodies to Carcinoembryonic-Antigen-Related Cell-Adhesion Molecules." In Vivo (Athens, Greece), vol. 35, no. 4, 2021, p. 1959, https://doi.org/10.21873/invivo.12463.